Skip to main content
. Author manuscript; available in PMC: 2009 Jun 2.
Published in final edited form as: Behav Pharmacol. 2009 Feb;20(1):99–108. doi: 10.1097/FBP.0b013e3283242fc2

Table 1.

Median (25th and 75th percentile in parentheses) trial-ready and choice-response latencies (in seconds) during control, saline and drug sessions for both phases of the experiment

Control Saline 0.03 (mg/kg) 0.1 (mg/kg) 0.3 (mg/kg) 1.0 (mg/kg) 3.0 (mg/kg)
Nicotine phase
 Trial ready 1.05 (0.72/1.54) 1.05 (0.73/1.55) 0.99 (0.70/1.52) 0.98 (0.66/1.40) 1.00 (0.70/1.43) 1.10 (0.70/1.79) 1.25 (0.81/2.27)
 Choice 1.05 (0.71/1.56) 0.99 (0.70/1.45) 0.93 (0.65/1.38) 1.00 (0.68/1.44) 1.00 (0.68/1.42) 1.13 (0.78/1.80) 1.35 (0.86/2.54)
Mecamylamine phase Nic Nic+Mec
 Trial ready 0.93 (0.60/1.40) 1.00 (0.65/1.47) 1.59 (0.98/2.25) 1.50 (0.90/2.92)
 Choice 0.98 (0.70/1.43) 1.00 (0.65/1.50) 0.93 (0.65/1.51) 1.63 (0.93/3.10)

Mec, mecamylamine; Nic, nicotine.